Ingenious Med, developer of the nation’s leading point-of-care platform for aligning physicians, their care teams, and their extended care teams, today announced that it has added Joe Marabito to its executive team as chief executive officer. Marabito is joining Ingenious Med to replace retiring president and CEO S. Hart Williford. Williford will serve as chairman of Ingenious Med’s board of directors.
With more than 25 years of healthcare industry experience, Marabito brings extensive operational, consulting, and strategic experience to the company from his various executive roles at healthcare organizations, leading providers of software solutions, and other services organizations within the healthcare IT sector.
“For the past eight years Ingenious Med has experienced explosive growth. Under Joe’s leadership, I am certain Ingenious Med will continue along that path, which has earned us a spot on the coveted Inc. 5000 list of fastest growing companies four times,” said Williford.
Marabito formerly served as president and CEO of ikaSystems, which offers an enterprise-level, cloud-based platform that administers Commercial, Medicare, Medicaid, and Health Exchange lines of business for payers and providers. He also held senior executive positions at Medco, Accenture, NaviNet, and Blue Cross Blue Shield of Missouri.
“Ingenious Med is a terrific company, with the right solution at the right time for professionals and institutions who deliver quality healthcare. Its innovative platform improves care delivery every day for its customers. Ingenious Med’s IM1 platform has been chosen by a marquee list of customers, including nine of the 10 largest healthcare systems in the nation, as well as eight of the 10 largest hospitalist companies in the nation. That definitively demonstrates Ingenious Med’s solutions are closely aligned with critical needs of leading healthcare organizations,” said Marabito. “The industry is at an inflection point, as the U.S. healthcare system accelerates its journey from volume to value, and Ingenious Med is at the center of that movement. I look forward to helping the company continue along its stellar growth path, and to tackling some of the biggest challenges facing the healthcare industry.”
